Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2006

View Archived Issues

Treatment-related anemia, hypersensitivity addressed at gastrointestinal cancer congress

Zenyth Therapeutics recaps recent highlights

Lee's to begin clinical testing of Declotana in China

MediWound begins phase III trials for wound healing product

Norwood Immunology begins phase II study in autologous BMT cancer patients

NICE recommends Pegasys for first-line treatment of chronic hepatitis B

Actilon begins new phase II study in chronic hepatitis C infection

Study results further support utility of Niaspan

Inotek advances IMS into phase I study

Enrollment ceased in Genzyme's phase II cardiac cell therapy study

PTHrP-positive primary breast tumors are less invasive and associated with improved survival

IKK represents a potential target for melanoma therapy

Monogram Biosciences collaborates with Merck on phase III trials of MK-0518

Recent Gruenenthal patent reports novel analgesic agents

Agents with potential utility in the treatment of metabolic disorders described in recent patents

Preclinical update of SLV-308 presented at 1st World Parkinson Congress

CpG-7909 may be an effective adjuvant to anthrax vaccine

VaxGen presents preclinical and clinical data on their attenuated smallpox vaccine LC16m8

CHMP recommends European approval of Preotact

European CHMP hands down positive opinion for Erbitux in head & neck cancer

Pramipexole recommended for approval in E.U. for restless legs syndrome

BioPartners receives positive Europe opinion for Valtropin

Fast track status for tolvaptan in autosomal dominant polycystic kidney disease

Positive European opinion for Evoltra in relapsed or refractory pediatric ALL

Approvable letter for zoledronic acid in Paget's disease

DuoTrav eye drops recommended for approval in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...